215 related articles for article (PubMed ID: 10949908)
1. Myocardial postischemic injury is reduced by polyADPripose polymerase-1 gene disruption.
Pieper AA; Walles T; Wei G; Clements EE; Verma A; Snyder SH; Zweier JL
Mol Med; 2000 Apr; 6(4):271-82. PubMed ID: 10949908
[TBL] [Abstract][Full Text] [Related]
2. Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences.
Liaudet L; Szabó E ; Timashpolsky L; Virág L; Cziráki A; Szabó C
Br J Pharmacol; 2001 Aug; 133(8):1424-30. PubMed ID: 11498530
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
4. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.
Halmosi R; Berente Z; Osz E; Toth K; Literati-Nagy P; Sumegi B
Mol Pharmacol; 2001 Jun; 59(6):1497-505. PubMed ID: 11353811
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose) polymerase-1 hyperactivation and impairment of mitochondrial respiratory chain complex I function in reperfused mouse hearts.
Zhou HZ; Swanson RA; Simonis U; Ma X; Cecchini G; Gray MO
Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H714-23. PubMed ID: 16582021
[TBL] [Abstract][Full Text] [Related]
6. Enhanced ADP-ribosylation and its diminution by lipoamide after ischemia-reperfusion in perfused rat heart.
Szabados E; Fischer GM; Gallyas F; Kispal G; Sumegi B
Free Radic Biol Med; 1999 Nov; 27(9-10):1103-13. PubMed ID: 10569643
[TBL] [Abstract][Full Text] [Related]
7. BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase.
Szabados E; Literati-Nagy P; Farkas B; Sumegi B
Biochem Pharmacol; 2000 Apr; 59(8):937-45. PubMed ID: 10692558
[TBL] [Abstract][Full Text] [Related]
8. Increased poly(ADP-ribosyl)ation in peripheral leukocytes and the reperfused myocardium tissue of rats with ischemia/reperfusion injury: prevention by 3-aminobenzamide treatment.
Zhang LQ; Qi GX; Jiang DM; Tian W; Zou JL
Shock; 2012 May; 37(5):492-500. PubMed ID: 22266967
[TBL] [Abstract][Full Text] [Related]
9. A novel and orally active poly(ADP-ribose) polymerase inhibitor, KR-33889 [2-[methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1H-benzimidazole-4-carboxylic acid amide], attenuates injury in in vitro model of cell death and in vivo model of cardiac ischemia.
Oh KS; Lee S; Yi KY; Seo HW; Koo HN; Lee BH
J Pharmacol Exp Ther; 2009 Jan; 328(1):10-8. PubMed ID: 18836068
[TBL] [Abstract][Full Text] [Related]
10. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle.
Thiemermann C; Bowes J; Myint FP; Vane JR
Proc Natl Acad Sci U S A; 1997 Jan; 94(2):679-83. PubMed ID: 9012844
[TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia.
Eliasson MJ; Sampei K; Mandir AS; Hurn PD; Traystman RJ; Bao J; Pieper A; Wang ZQ; Dawson TM; Snyder SH; Dawson VL
Nat Med; 1997 Oct; 3(10):1089-95. PubMed ID: 9334719
[TBL] [Abstract][Full Text] [Related]
13. ROS-mediated PARP activity undermines mitochondrial function after permeability transition pore opening during myocardial ischemia-reperfusion.
Schriewer JM; Peek CB; Bass J; Schumacker PT
J Am Heart Assoc; 2013 Apr; 2(2):e000159. PubMed ID: 23598272
[TBL] [Abstract][Full Text] [Related]
14. Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase.
Liaudet L; Yang Z; Al-Affar EB; Szabó C
Mol Med; 2001 Jun; 7(6):406-17. PubMed ID: 11474134
[TBL] [Abstract][Full Text] [Related]
15. Genetic deletion of CD38 confers post-ischemic myocardial protection through preserved pyridine nucleotides.
Boslett J; Helal M; Chini E; Zweier JL
J Mol Cell Cardiol; 2018 May; 118():81-94. PubMed ID: 29476764
[TBL] [Abstract][Full Text] [Related]
16. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
17. Activation of poly(ADP-ribose) polymerase in circulating leukocytes during myocardial infarction.
Murthy KG; Xiao CY; Mabley JG; Chen M; Szabó C
Shock; 2004 Mar; 21(3):230-4. PubMed ID: 14770035
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose) polymerase contributes to the development of myocardial infarction in diabetic rats and regulates the nuclear translocation of apoptosis-inducing factor.
Xiao CY; Chen M; Zsengellér Z; Szabó C
J Pharmacol Exp Ther; 2004 Aug; 310(2):498-504. PubMed ID: 15054118
[TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribose) accumulation and enhancement of postischemic brain damage in 110-kDa poly(ADP-ribose) glycohydrolase null mice.
Cozzi A; Cipriani G; Fossati S; Faraco G; Formentini L; Min W; Cortes U; Wang ZQ; Moroni F; Chiarugi A
J Cereb Blood Flow Metab; 2006 May; 26(5):684-95. PubMed ID: 16177811
[TBL] [Abstract][Full Text] [Related]
20. Minocycline protects cardiac myocytes against simulated ischemia–reperfusion injury by inhibiting poly(ADP-ribose) polymerase-1.
Tao R; Kim SH; Honbo N; Karliner JS; Alano CC
J Cardiovasc Pharmacol; 2010 Dec; 56(6):659-68. PubMed ID: 20881608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
